Rnai agents for anti-sars coronavirus therapy
A technology of SARS virus and coronavirus, which is applied in the field of compositions for the treatment of severe acute respiratory syndrome, and can solve problems such as inadequate treatment of lung and respiratory diseases
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0047] The present invention provides compositions and methods for treating coronavirus infection in mammals, especially primates and humans, by using siRNA molecules delivered in vivo to inhibit coronavirus gene expression.
[0048] More specifically, the present invention provides the inhibition of genes or genomic material in lung tissue. Provides therapeutic or preventive therapy for infectious diseases by inhibiting the genes or genomes of viruses. The present invention provides short double-stranded RNA oligonucleotides or siRNAs that inhibit gene expression with mismatched sequences or inhibit RNA viral genomes. The invention also provides nucleic acid (including RNA or DNA) therapeutics. The invention also provides methods of delivery into lung tissue. In one embodiment, the present invention provides inhibitors of coronaviruses, especially SARS coronaviruses. Inhibitors of these respiratory tract infections, including respiratory viral infections, are useful as the...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com